model
PCPCC Website with Behavioral Health Integration in the Medical Home
FYI: New article about pharmacist's impact on patient care
Tic Suppression: The Medical Model
Journal of Child and Adolescent Psychopharmacology Aug 2010, Vol. 20, No. 4: 263-276. (Source: Journal of Child and Adolescent Psychopharmacology)
Implementing a Referral to Telephone Tobacco Cessation Services in Louisiana Community Pharmacies: A Pilot Study
BACKGROUND: With one of the highest rates of tobacco dependence in
the nation, Louisiana has been searching for economical and effective methods
for assisting patients in cessation efforts. Community pharmacists are in an
excellent position to promote tobacco cessation due to their availability to
patients. The "Ask-Advise-Refer" model is a short intervention in
which patients desiring to quit smoking are referred to free tobacco cessation
telephone counseling services.
Polygenic Heterogeneity: A Complex Model of Genetic Inheritance in Psychiatric Disorders
A polygenic/threshold model of psychiatric disorder was first introduced more than 40 years ago by Gottesman and Shields (). They proposed, following on from the seminal work of Falconer (), that what is inherited is not so much a disorder as a liability to disorder contributed to by multiple genetic and environmental effects. What has emerged in recent studies is an even more complex pattern of polygenic heterogeneity whereby phenotypically different syndromes appear to result from overlapping liabilities () (). An article in the current issue of Biological Psychiatry by Pagnamenta et al.
Movies on Addition
Learning as a Model for Neural Plasticity in Major Depression
Background: The neuroplasticity hypothesis of depression proposes that a dysfunction of neural plasticity—the basic ability of living organisms to adapt their neural function and structure to external and internal cues—might represent a final common pathway underlying the biological and clinical characteristics of the disorder.
Effectiveness of Exogenous Albumin Administration for the Prevention of Ifosfamide-Induced Encephalopathy
Pharmacotherapy 30(8): 812-817 Abstract Study Objectives. To assess the effectiveness of prophylactic albumin for the prevention of ifosfamide-induced encephalopathy (IIE), and to describe risk factors for IIE and investigate the predictive potential of a novel risk-stratification model for IIE. Design. Retrospective analysis. Setting. Single academic medical center. Patients. Forty-one adults who received 93 chemotherapy cycles of regimens that included ifosfamide for the treatment of hematologic or solid tumor malignancy between November 2007 and November 2008.